SAN FRANCISCO--(BUSINESS WIRE)--VIA Pharmaceuticals (NASDAQ: VIAP) a biotechnology company focused on the development of compounds for the treatment of cardiovascular disease, today announced that Lawrence Cohen, chief executive officer of VIA, will present a company update at ThinkEquity Partners 5th Annual Growth Conference in San Francisco on Monday September 17, 2007 at 7:30 a.m. PT.
